Actively Recruiting
Factors Predicting Loss of Functional Independence in Adults With Alzheimers Disease or Related Memory Disorders in a Regional Real-World Study
Led by Hospices Civils de Lyon · Updated on 2022-05-02
5400
Participants Needed
5
Research Sites
417 weeks
Total Duration
AI-Summary
What this Trial Is About
Alzheimers disease and related disorders ADRD are disabling conditions characterized by cognitive decline, loss of independence, and behavioral changes. Without a current cure, this study aims to identify factors that predict how patients ability to function changes over time. The research involves building a regional database of medical records from patients in the Auvergne Rhone-Alpes region of France to better understand disease progression. Participants are patients with memory complaints or neurocognitive disorders who undergo medical examinations at memory centers. The study follows about 5400 patients over a maximum of 10 years, with evaluations every 6 to 12 months. These assessments measure functional autonomy and include tests like IADL, DAD6, New AGGIR, NPI, and mini-Zarit to evaluate independence, behavior, and caregiver burden. During the study, patients receive standard medical care and extensive evaluations at regular intervals. Researchers track changes in each patients functional autonomy over time as the main outcome. The study began in September 2020 and will continue until March 2032, allowing long-term observation of disease progression and its impact on daily living.
CONDITIONS
Brief Title
Predictive Factors of Autonomy Loss in Real-life Cohort
Research Team
P
Pierre Krolak-Salmon, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here